Health
Small molecule, big potential for treating prostate cancer – MIT News
A team of researchers led by MIT professor Angela Koehler identified a CDK9 inhibitor that could be developed into a treatment for castration-resistant prostate…
Prostate cancer growth is often driven by male sex hormones called androgens. Hormone therapy is commonly administered to lower the level of androgens in the body, but relapse is common when the cancer cells develop resistance to these therapies.
A multidisciplinary team of cancer researchers led by Angela Koehler, the Samuel A. Goldblith Career Development Professor in Applied Biology and a member of MITs Koch Institute for Integrative Cancer Research, has identified a small molecule that can selectively…
-
Business6 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Business22 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
General8 hours agoChris Bowen’s 200 tonne carbon footprint nightmare
-
Noosa News17 hours agoTeen arrested over vandalism at Airbnb party in East Brisbane